6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
13m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
39m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
39m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
40m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
40m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Axsome Therapeutics Inc (NASDAQ:AXSM) — investor relations, events, news, and company updates on 6ix.

Latest News

Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Financials

Revenue

$638.5 M

Market Cap

$8.62 B

EPS

-3.67

Community Chat

Ask AI